Mustang Bio logo
Mustang Bio MBIO
€ 0.62 -2.28%

Geschäftsbericht 2025
hinzugefügt 19.03.2026

report update icon

Mustang Bio Gesamtverbindlichkeiten 2011-2026 | MBIO

Gesamtverbindlichkeiten Jährlich Mustang Bio

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
8.06 M 13.2 M 17.6 M 46.1 M 12.8 M 11.5 M 21.8 M 6.36 M 3.66 M 3.22 M 4.13 M - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
46.1 M 3.22 M 13.5 M

Gesamtverbindlichkeiten Vierteljährlich Mustang Bio

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
9.59 M 10.2 M 11.3 M 15.8 M 16.8 M 19.5 M 16.6 M 15.4 M 43.8 M 46.1 M 44.5 M 39.9 M 39.6 M 12.8 M 12.5 M 8.18 M 8.46 M 11.5 M 11.5 M 11.5 M 11.5 M 21.8 M 21.8 M 21.8 M 22 M 6.36 M 6.36 M 6.36 M 6.36 M 3.66 M 3.66 M 3.66 M 3.66 M 3.22 M 3.22 M 3.22 M 3.22 M 4.13 M 4.13 M - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
46.1 M 3.22 M 14.5 M

Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Gesamtverbindlichkeiten Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
1.98 B - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
13.8 M - 1052.0 % $ 415 M usaUSA
Verastem Verastem
VSTM
189 M $ 5.04 -4.73 % $ 349 M usaUSA
VistaGen Therapeutics VistaGen Therapeutics
VTGN
14 M $ 0.57 -5.87 % $ 17.6 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
21.9 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
6.99 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
62.5 M - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
7.27 M - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
45.1 M - 0.23 % $ 488 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
75.8 M - - $ 3.67 B usaUSA
I-Mab I-Mab
IMAB
707 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
6.45 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
215 M - 2.54 % $ 160 B franceFrance
Albireo Pharma Albireo Pharma
ALBO
126 M - -0.23 % $ 916 M usaUSA
Biophytis SA Biophytis SA
BPTS
20.4 M - -13.47 % $ 169 M franceFrance
Aileron Therapeutics Aileron Therapeutics
ALRN
7.24 M - 10.36 % $ 9.8 M usaUSA
Aptinyx Aptinyx
APTX
28.4 M - -39.0 % $ 4.57 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
6.46 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
8.16 M - -1.52 % $ 24.7 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
110 M - -6.81 % $ 3.04 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
37.2 M - - $ 26.5 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.43 M - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
76.6 M - -11.76 % $ 5.79 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
395 M - -24.86 % $ 820 K usaUSA
bluebird bio bluebird bio
BLUE
425 M - - $ 546 M usaUSA
Acasti Pharma Acasti Pharma
ACST
5.38 M - 4.01 % $ 150 M canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.1 B - - - russiaRussia
Avid Bioservices Avid Bioservices
CDMO
276 M - - $ 789 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
109 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
28.4 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
7.89 M - -9.65 % $ 45.9 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
288 M $ 12.41 -11.1 % $ 1.88 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
3.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
BioDelivery Sciences International BioDelivery Sciences International
BDSI
137 M - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
68.8 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
140 M - - $ 3.74 B usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
4.1 M $ 1.05 -3.67 % $ 21.5 M israelIsrael
Enochian Biosciences Enochian Biosciences
ENOB
29.6 M - - $ 40.5 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
470 M - - $ 867 M germanyGermany
Summit Therapeutics Summit Therapeutics
SMMT
92.3 M $ 16.58 -3.94 % $ 12.4 B britainBritain
Zymeworks Zymeworks
ZYME
140 M $ 24.18 -2.07 % $ 1.25 B canadaCanada
AbbVie AbbVie
ABBV
97.3 B $ 209.4 -0.83 % $ 370 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
390 M $ 3.27 -2.39 % $ 977 M canadaCanada
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
5.4 M - -74.18 % $ 955 K usaUSA
Altimmune Altimmune
ALT
55 M $ 3.02 -5.63 % $ 266 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
355 M $ 1.21 -6.2 % $ 309 M britainBritain
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
4.18 B $ 317.36 -3.29 % $ 41.6 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
93.3 M $ 2.6 -2.8 % $ 16.3 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
18 M $ 4.29 -3.6 % $ 822 M canadaCanada